Syneos Health Stock

Syneos Health EBIT

Delisted·Sep 29, 2023

The EBIT of Syneos Health (SYNH) as of Aug 7, 2026 is 403.19 M USD. In the previous year, EBIT was 389.28 M USD — a change of 3.57% (higher).

EBIT

403.19 MUSD

YoY

3.57%

Last updated:

In 2026, Syneos Health's EBIT was 403.19 M USD, a 3.57% increase from the 389.28 M USD EBIT recorded in the previous year.

The Syneos Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2020
293.14 base
Jan 1, 2021
389.28 base
Jan 1, 2022
403.19 base
Jan 1, 2023 (e)
608.37 base
Jan 1, 2024 (e)
690.92 base
Jan 1, 2025 (e)
741.06 base
Jan 1, 2026 (e)
831.30 base
Jan 1, 2027 (e)
914.94 base
YEAREBIT (M USD)
2027 est 914.94
2026 est 831.30
2025 est 741.06
2024 est 690.92
2023 est 608.37
2022 403.19
2021 389.28
2020 293.14
2019 324.54
2018 307.75
2017 -28.87
2016 155.36
2015 152.36
2014 63.64
2013 31.46
2012 -37.53
2011 -40.20
Access this data via the Eulerpool API

Syneos Health Revenue

Syneos Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
4.42 B USD
293.14 M USD
192.79 M USD
Jan 1, 2021
5.21 B USD
389.28 M USD
234.83 M USD
Jan 1, 2022
5.39 B USD
403.19 M USD
266.50 M USD
Jan 1, 2023 (e)
5.14 B USD
608.37 M USD
355.96 M USD
Jan 1, 2024 (e)
5.25 B USD
690.92 M USD
405.63 M USD
Jan 1, 2025 (e)
5.60 B USD
741.06 M USD
471.00 M USD
Jan 1, 2026 (e)
5.69 B USD
831.30 M USD
506.62 M USD
Jan 1, 2027 (e)
5.91 B USD
914.94 M USD
571.01 M USD

Syneos Health Margins

Syneos Health stock margins

The Syneos Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Syneos Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Syneos Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
23.05 %
6.64 %
4.37 %
Jan 1, 2021
23.37 %
7.47 %
4.50 %
Jan 1, 2022
23.26 %
7.48 %
4.94 %
Jan 1, 2023 (e)
23.26 %
11.85 %
6.93 %
Jan 1, 2024 (e)
23.26 %
13.17 %
7.73 %
Jan 1, 2025 (e)
23.26 %
13.24 %
8.41 %
Jan 1, 2026 (e)
23.26 %
14.62 %
8.91 %
Jan 1, 2027 (e)
23.26 %
15.48 %
9.66 %

Syneos Health Stock analysis

What does Syneos Health do? Syneos Health is a US-based pharmaceutical and biotech service company. They specialize in providing integrated solutions for clinical research, commercial services, and data analysis. The company was founded in 2017 through the merger of two leading service companies, INC Research and inVentiv Health. Today, Syneos Health is one of the largest providers of clinical and commercial services in the pharmaceutical and biotech industry. They support their customers in the development and marketing of medications, diagnostics, and medical devices by offering a wide range of services including planning and conducting clinical trials, data analysis and management, and product marketing. Syneos Health operates in four business areas: clinical solutions, commercial solutions, consulting services, and clinical data analysis. Their primary focus is on delivering customer-centric services that cover various aspects of the pharmaceutical and biotech industry value chain. Within their clinical and medical segment, they conduct clinical trials and provide supporting services. They have expertise in clinical research and have successfully executed numerous studies. Syneos Health also offers consulting services in the areas of data management systems and clinical trials. In the commercial segment, they assist customers with marketing, sales promotion, and channel management to ensure the successful launch and sales of products. They provide training for sales staff, market research and analysis, and continuous support from sales and marketing experts. Their consulting services encompass strategy consulting, market research, branding, and communication. They also assist with the development, implementation, and validation of clinical trials, literature research, and regulatory support. Syneos Health's clinical data analysis involves analyzing large data sets to gain insights into the healthcare industry. They utilize cutting-edge technologies such as Big Data Analytics and Machine Learning to provide customers with valuable insights that aid in decision-making. In addition to clinical trials and consulting, Syneos Health offers modern technologies for the development and marketing of medications. This includes Virtual Reality solutions, personalized patient programs for chronic disease treatment, and digital platforms for data collection, analysis, and management. Syneos Health serves globally operating pharmaceutical and biotech companies that rely on their services to develop and market innovative medications and treatment methods. Customers value Syneos Health's expertise and trust that the company will help them successfully bring their products to market. Overall, Syneos Health is a leading company in the pharmaceutical and biotech industry. Their integrated services enable customers to work faster and more effectively. By combining expertise in clinical research, commercial solutions, consulting services, and clinical data analysis, Syneos Health offers innovative and successful solutions to its customers. Syneos Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Syneos Health's EBIT

Syneos Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Syneos Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Syneos Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Syneos Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Syneos Health stock

EBIT of Syneos Health is 403.19 M USD in 2026.

EBIT of Syneos Health changed from 389.28 M USD to 403.19 M USD, representing a 3.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Syneos Health since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Syneos Health historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Syneos Health

All Key Metrics — Syneos Health